Physical Functioning in Older Patients With Breast Cancer: A Prospective Cohort Study in the TEAM Trial

Abstract

Background. Previous retrospective studies have shown that physical functioning in older cancer survivors is affected after treatment, yet prospective data are lacking. The aim of this study was to assess change in physical functioning in different age groups of patients with hormone receptor-positive breast cancer who were enrolled in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) phase III trial. Methods. Two physical parameters were assessed. Physical functioning was assessed using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire 1 year (T1) and 2 years (T2) after diagnosis. Physical activity was measured in metabolic equivalent of task (MET) hours/week at T1 and T2. Physical activity before diagnosis (T0) was assessed retrospectively at the T1 questionnaire. Patients were divided into three age groups: ,60, 60-69, and $70

Quality of life versus length of life considerations in cancer patients: A systematic literature review

“…Considerations should include patient intolerance to certain chemotherapy agents or surgery, as well as an understanding that they may never reach their preoperative baseline physical fitness again after treatment. This "step down" in function tends to be more prominent in the older age group, 47,48 an effect that is widely recognized across many medical interventions in older patients. They may feel that time spent receiving treatment may not be worth the extension of life for a relatively short period.…”

Association Between Symptom Burden and Physical Function in Older Patients with Cancer

“…Because the patients included in the study consists of those referred to the geriatric oncology clinics at the two sites, there is a potential of selection and referral bias arising from physician, patient, disease, and other related factors. It included patients at any time point of their cancer treatment, some of whom had cancer surgery, radiation, hormonal therapy, or chemotherapy that can affect their symptom burden and functional status . A symptom inventory more specific to patients on cancer therapy may clarify which symptoms are associated with the most impairment and are highest priorities for intervention.…”

“…It included patients at any time point of their cancer treatment, some of whom had cancer surgery, radiation, hormonal therapy, or chemotherapy that can affect their symptom burden and functional status. 10 A symptom inventory more specific to patients on cancer therapy may clarify which symptoms are associated with the most impairment and are highest priorities for intervention. Due to the limited availability of cancer treatment information in our study population, the effect of treatment on outcome was not evaluated in multivariate models that may bias the estimates.…”

Health‐Related Quality of Life in a Predictive Model for Mortality in Older Breast Cancer Survivors

“…Health‐related quality of life (HRQOL) encompasses the multiple domains of a person's well‐being—including mental health, physical function, and social support—and how disease affects these domains . Evidence suggests that breast cancer and its treatment might affect the HRQOL of older women differently than younger survivors . Moreover, when choosing treatments older adults with cancer may value HRQOL just as much, if not more, than survival …”